fda decision on tirzepatide Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Is Tirzepatide FDA Approved?

company is using 'deceptive marketing' to sell copycat versions of its obesity blockbuster Wegovy.

Easily fill out and eSign the Caremark Prior Authorization Request Form with pdfFillers secure online editor

Some businesses are trying to lure diners on GLP-1s with miniature meals and tiny tasting menus.

Mechanism of Action Blocks angiotensin II type 1 (AT1) receptors Prevents vasoconstriction and aldosterone secretion Results in lower blood pressure and reduced cardiac workload Unlike ACE inhibitors, it does not cause cough (less bradykinin effect) 2

GLP-2 analogs positively influence nutrient absorption in animal models and humans, although continued therapy is likely needed for sustained effects

Purpose of Review There has been a rise in popularity and use of GLP-1 receptor agonists since their approval for obesity management